It is hypothesized that recurrent and metastatic disease are predominantly derived from the less differentiated cells with stem-like characteristics that would retain the ability to produce progeny with changes in the expression of key markers, resulting in the observed alterations in ERα expression in recurrent and metastatic disease as compared to the primary tumor. This evidence concerns the gene ESR1 and metastatic neoplasm.